Shanghai Fosun Pharmaceutical Stock Retained Earnings
SFOSF Stock | USD 1.53 0.00 0.00% |
Shanghai Fosun Pharmaceutical fundamentals help investors to digest information that contributes to Shanghai Fosun's financial success or failures. It also enables traders to predict the movement of Shanghai Pink Sheet. The fundamental analysis module provides a way to measure Shanghai Fosun's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Shanghai Fosun pink sheet.
Shanghai |
Shanghai Fosun Pharmaceutical Company Retained Earnings Analysis
Shanghai Fosun's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current Shanghai Fosun Retained Earnings | 10.37 B |
Most of Shanghai Fosun's fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Shanghai Fosun Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
Competition |
Based on the latest financial disclosure, Shanghai Fosun Pharmaceutical has a Retained Earnings of 10.37 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The retained earnings for all United States stocks is 11.14% lower than that of the firm.
Shanghai Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Shanghai Fosun's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Shanghai Fosun could also be used in its relative valuation, which is a method of valuing Shanghai Fosun by comparing valuation metrics of similar companies.Shanghai Fosun is currently under evaluation in retained earnings category among related companies.
Shanghai Fundamentals
Return On Equity | 0.0756 | |||
Return On Asset | 0.0204 | |||
Profit Margin | 0.08 % | |||
Operating Margin | 0.07 % | |||
Current Valuation | 15.52 B | |||
Shares Outstanding | 551.94 M | |||
Shares Owned By Insiders | 0.07 % | |||
Shares Owned By Institutions | 35.60 % | |||
Price To Earning | 13.80 X | |||
Price To Book | 1.45 X | |||
Price To Sales | 0.31 X | |||
Revenue | 39.01 B | |||
Gross Profit | 18.71 B | |||
EBITDA | 8.71 B | |||
Net Income | 4.74 B | |||
Cash And Equivalents | 14.64 B | |||
Cash Per Share | 5.49 X | |||
Total Debt | 9.05 B | |||
Debt To Equity | 0.64 % | |||
Current Ratio | 1.00 X | |||
Book Value Per Share | 16.30 X | |||
Cash Flow From Operations | 3.95 B | |||
Earnings Per Share | 0.21 X | |||
Number Of Employees | 36.28 K | |||
Beta | 0.76 | |||
Market Capitalization | 12.25 B | |||
Total Asset | 93.29 B | |||
Retained Earnings | 10.37 B | |||
Working Capital | (817 M) | |||
Current Asset | 10.27 B | |||
Current Liabilities | 11.09 B | |||
Z Score | 0.6 | |||
Annual Yield | 0.03 % | |||
Net Asset | 93.29 B | |||
Last Dividend Paid | 0.56 |
About Shanghai Fosun Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Shanghai Fosun Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Shanghai Fosun using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Shanghai Fosun Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shanghai Fosun Pharmaceutical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Shanghai Pink Sheet analysis
When running Shanghai Fosun's price analysis, check to measure Shanghai Fosun's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanghai Fosun is operating at the current time. Most of Shanghai Fosun's value examination focuses on studying past and present price action to predict the probability of Shanghai Fosun's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanghai Fosun's price. Additionally, you may evaluate how the addition of Shanghai Fosun to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |